Vaccine Preparedness — Are We Ready for the Next Influenza Pandemic?
- 12 June 2008
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (24) , 2540-2543
- https://doi.org/10.1056/nejmp0803650
Abstract
The quest for a fully immunogenic vaccine against influenza H5N1 viruses has gone on for more than 10 years, since this family of potentially pandemic viruses emerged as a cause of human disease in Hong Kong in 1997. H5N1 has caused 381 human cases of influenza, with a mortality rate exceeding 60%. H5 strains have now been found in birds throughout much of the world (though not yet in the Americas), and human illness has occurred in 14 countries throughout Asia and in northern Africa.1 The much-feared rapid spread through and between communities, however, has not occurred. Aside from small clusters of cases within families, each human case has been associated with close contact with poultry. The culling of poultry in the face of recognized bird disease has been a major defense strategy since the first outbreak.Keywords
This publication has 2 references indexed in Scilit:
- A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell CultureNew England Journal of Medicine, 2008
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) VaccineNew England Journal of Medicine, 2006